Faculty of Medicine, Federal University of Rio de Janeiro, R. Prof. Rodolpho Paulo Rocco, 255 - Cidade Universitária da Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, 21941-617, Brazil.
Faculty of Medicine, State University of Ponta Grossa, Ponta Grossa, PR, Brazil.
Neurosurg Rev. 2024 Apr 23;47(1):181. doi: 10.1007/s10143-024-02414-z.
The treatment for peripheral nerve sheath tumors (PNSTs) is based on surgical excision and the primary goal is to improve symptoms whilst preserving neurological function. In order to improve this technique, surgeons may use sodium fluorescein (SF) to help visualize the neoplasm and, consequently, facilitate its removal. Aiming to assess the efficacy of this emerging surgical strategy, we conducted a systematic review and single-arm meta-analysis. We conducted a systematic search on the PubMed, Embase, and Web of Science databases, following the PRISMA guidelines. Studies without outcomes of interest, case series with less than four patients, letters, comments, technical notes, editorials, reviews, and basic research papers were excluded. The outcomes considered for this study were: the number of tumors that achieved total resection, subtotal resection, or near total resection, the approach/technique utilized by the surgeon, SF-related complications, and total complications. Five studies, with a total of 175 individuals, were included in our survey. Notably, 70% of the neoplasms presented by the patients were schwannomas. Considering extracranial lesions, we found a proportion of 96% (95% CI: 88 - 100%) in total resection, 0% (95% CI: 0-1%) in near total resection, and 4% (95% CI: 0-12%) in subtotal resection, all linked to an amount of 185 analyzed PNSTs. Furthermore, a proportion of 1% (95% CI: 0 - 2%) in SF-related complications was spotted among 183 patients. Finally, total complications analysis accounted for 11% (95% CI: 0 - 25%) among 183 individuals. We concluded that SF-assisted resection of PNSTs is a suitable and relatively safe technique, linked to minimum complications, of which the majority was not associated with the chemical compound itself. Future research is necessary to increase the number of patients available in the current literature and, therefore, enhance future analyses.
外周神经鞘瘤 (PNST) 的治疗基于手术切除,主要目标是改善症状,同时保留神经功能。为了改进这项技术,外科医生可能会使用荧光素钠 (SF) 来帮助可视化肿瘤,从而更方便地切除肿瘤。为了评估这种新兴的手术策略的效果,我们进行了系统评价和单臂荟萃分析。我们按照 PRISMA 指南在 PubMed、Embase 和 Web of Science 数据库中进行了系统检索。排除了没有研究结果的文章、少于 4 例患者的病例系列、信件、评论、技术说明、社论、综述和基础研究论文。本研究考虑的结果包括:完全切除、次全切除或近全切除的肿瘤数量、外科医生使用的方法/技术、SF 相关并发症和总并发症。共有 5 项研究,总计 175 人纳入我们的研究。值得注意的是,患者的神经瘤中有 70%为神经鞘瘤。对于颅外病变,我们发现完全切除的比例为 96%(95%可信区间:88-100%),近全切除的比例为 0%(95%可信区间:0-1%),次全切除的比例为 4%(95%可信区间:0-12%),所有这些均与 185 个分析的 PNST 相关。此外,在 183 名患者中发现了 1%(95%可信区间:0-2%)的 SF 相关并发症。最后,在 183 名患者中,总并发症分析占 11%(95%可信区间:0-25%)。我们得出结论,SF 辅助切除 PNST 是一种合适且相对安全的技术,并发症最小,其中大多数与化学物质本身无关。需要进一步的研究来增加目前文献中可用的患者数量,从而增强未来的分析。